Genetron | IPO Presentation Deck | 41 slides

Genetron · 2020-07
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

41
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
summarize
04
other
Open slide detailBeat · Team
05
The slide uses a structured layout to highlight market rankings and key performance metrics for each business unit.show_traction
Open slide detailBeat · Team
06
LDT likely stands for Laboratory Developed Test.show_traction
07
The slide combines a horizontal timeline with a geographic map and investor logos.show_traction
08
Includes a list of key comparable companies at the bottom.inspire_vision
09
The slide uses a grid-like layout to categorize different types of business traction.show_traction
10
transition
Open slide detailBeat · Problem
11
The slide uses a comparative framework to highlight the market opportunity for precision oncology in China.size_opportunity
Open slide detailBeat · Problem
12
Uses NIPT as a proxy/precedent for market adoption potential.size_opportunity
Open slide detailBeat · Market Size
13
transition
14
The slide uses a matrix to map cancer types to diagnostic/monitoring modalities and a donut chart for revenue breakdown.present_solution
Open slide detailBeat · Solution
15
The slide uses a Gantt-style chart to track product development stages from pre-clinical to approval.plan_implementation
Open slide detailBeat · Solution
16
The slide uses a visual mapping of hardware platforms to specific assay portfolios.present_solution
Open slide detailBeat · Solution
17
Uses a pyramid diagram to segment the ~1000 Class 3 Grade A hospitals in China by their capability to adopt in-hospital testing.plan_implementation
18
The slide uses a process diagram to visualize the workflow steps and a comparison table for key performance metrics.compare_peers
19
Uses test tube diagrams to visualize cost breakdown (Ex-hospital price, operating cost, ex-factory price, assay cost).compare_peers
20
The map visualizes the geographic footprint of regulatory/procurement approvals for Genetron's assays.show_traction
Open slide detailLoop · Cost Of Inaction
21
The slide uses a flow diagram to illustrate the clinical study methodology and results.show_traction
Open slide detailLoop · Cost Of Inaction
22
The table highlights key performance metrics like mutation detection, panel size, on-target rate, GC region coverage, cost, and throughput.compare_peers
Open slide detailLoop · Cost Of Inaction
23
The slide uses a split-layout: left side focuses on clinical study traction, right side focuses on market context and commercialization milestones.show_traction
Open slide detailLoop · Cost Of Inaction
24
Includes company logo and source citation.size_opportunity
Open slide detailLoop · Quick Win Big Bet
25
The slide uses a process flow diagram to map services to the drug development lifecycle.show_traction
26
The slide uses a matrix-like layout to compare the credentials of the CSO and CTO.other
27
Includes a table of specific industry-leading regulatory approvals and team metrics.show_traction
28
Includes footnotes regarding certification status and capacity metrics.establish_context
29
plan_implementation
30
plan_implementation
31
transition
32
Includes LDT test volume counts above the revenue bars.show_traction
33
Data presented as combo charts with bars for absolute USD values and lines for percentage margins.analyze_data
34
The slide uses a dual-axis approach (bar for absolute dollars, line for percentage of revenue) to demonstrate efficiency gains.analyze_data
35
The slide uses a dual-axis approach (bar for absolute values, line for percentages) to demonstrate operational leverage.analyze_data
37
The diagram illustrates a typical VIE (Variable Interest Entity) structure used by Chinese companies to list offshore.other
38
Note (1) specifies an exchange rate of RMB/USD 6.9618.analyze_data
39
Includes a footnote regarding the exchange rate used for conversion.analyze_data
40
Includes exchange rate note for RMB/USD conversion.analyze_data
41
Data presented in 000's, with 2019 figures provided in both RMB and USD.analyze_data